<img height="1" width="1" style="display:none;" alt="" src="https://dc.ads.linkedin.com/collect/?pid=586106&amp;fmt=gif">

SUBSCRIBE HERE

Mattel wants to play "takeover"

Jun 6, 2019 4:02:00 PM

On 06/12/19 [09:51], Rumor Hound alerted a potential takeover of Mattel (NasdaqGSM: MAT; 11.40) by Hasbro (NasdaqGSM: HAS; 105.84). Rumor is substantiated by 48 sources; 12 of which have five-star reliability scores and 17 with source popularity scores 6 or greater. MAT shares were up 7%+ as of noon Wednesday on reports of a rejected & unsolicited merger offer by rival toymaker MGA Entertainment- who was subject of a lawsuit in 2004 by MAT.

> READ MORE

Healthy prospects for a Humana-Centene takover

May 30, 2019 3:14:00 PM

Beginning 05/06/19 and most recently on 05/28, Rumor Hound alerted a potential takeover of multi-national managed care organization Centene Corporation (NYSE: CNC; $56.23) by Humana (NYSE: HUM; $251.04) through both high reliability and popularity sources. Since 1H15, Humana has closed on 8 deals with an aggregate announced value of approx. $6.5B in cash. Kindred Healthcare has been the largest deal by value ($3.8B in 12/17) followed by Curo Health Services in 4/18 and Concentra in 3/15 valued at $1.4B and $1.0B, respectively. During the same timeframe and excluding WCG, Centene closed on 13 deals with an aggregate announced value of approx. $10.6B in cash.

> READ MORE

Aimmune not allergic to a takeover

May 24, 2019 2:57:00 PM

On 05/16/19, RumorHound platform alerted a potential takeover of Aimmune Therapeutics (NasdaqGSM:AIMT; $20.20) where no potential acquirer was mentioned. AIMT is a clinical stage biopharmaceutical company that develops therapies focused on desensitizing patients suffering from food allergies.

> READ MORE

Is a takeover in uniQure's genes

May 17, 2019 2:48:00 PM

On 05/17/19, RumorHound platform alerted a potential takeover of UniQure Biopharma N.V. (NasdaqGSM:QURE; $59.74) where no potential acquirer was mentioned. Our analyst identified Bristol-Myers Squibb (NYSE:BMY; $46.85) as a potential acquirer, although several other large pharma are likely following QURE closely. See below:

> READ MORE

Potential takeover of Portola Pharmaceuticals

May 10, 2019 2:19:00 PM

On 05/10/19 [10:39], Rumor Hound  alerted potential takeover of Portola Pharmaceuticals, (Nasdaq: $PTLA, $30.93) where no potential acquirer was mentioned. PTLA markets therapies Bevyxxa (betrixaban; Factor Xa inhibitor), an oral anticoagulant and Andexxa (andexanet alfa; coagulation factor Xa (recombinant), inactivated-zhzo) and is developing Cerdulatinib, an oral tx for follicular lymphoma (FL) in PhIIa and PRT2761 for allergic conjunctivitis.

> READ MORE

Is this the beginning of a boom in bank deals? $ZION

Apr 30, 2019 1:23:00 PM

After a long quiet period, U.S. bank mergers and acquisitions (M&A) activity seems to be back on the rise. On April 23, 2019, Rumor Hound sourced low popularity chatter on Zions Bancorporation (NASDAQ: ZION), a large U.S. regional bank based in Salt Lake City, Utah. While this is simply one source, this may be the beginning of a nascent boom in bank deals, especially after the surprise $66 billion mergers of regionals SunTrust Banks and BB&T.

> READ MORE

Entertaining takeover of Caesars

Apr 23, 2019 11:50:00 AM

Since April 2018, Rumor Hound has sourced significant chatter regarding takeover interest in Caesars Entertainment Corporation (NYSE: CZR), the Las Vegas-based owner of the eponymous casino chain. On April 16, 2019, Rumor Hound sourced information that the company’s Board of Directors was forming a transaction committee to evaluate potential deals or strategic alternatives. This was almost exactly one year from the first rumors originating from low popularity social media sources. With nearly a year of lead time until the company announced it was considering takeover approaches, Rumor Hound alerts traders, portfolio managers and analysts about events before wide dissemination.

> READ MORE

Significant chatter around Zayo

Apr 16, 2019 11:38:00 AM

Since last July, Rumor Hound has sourced significant chatter about Zayo Group Holdings, Inc. (NYSE: ZAYO) , a Boulder, Colorado-based telecommunications infrastructure company. After initial chatter from lower popularity, high-reliability sources, higher popularity sources are now confirming Zayo as a target of significant interest.

> READ MORE

Who will acquire 'The Medicines Company'?

Apr 10, 2019 12:22:00 PM

On 04/10/19 [07:51], Rumor Hound alerted potential takeover of The Medicines Company, (Nasdaq:GSM, $28.45) where no potential acquirer was mentioned. This ‘MDCO takeover’ rumor may be rooted in a note published by Citigroup Inc. (NYSE, C, $65.48) analyst regarding expectation of near-term PhIII safety data from ORION program (particularly ORION-10) evaluating lead candidate Inclisiran, a small interfering ribonucleic acid (siRNA) therapy to lower low-density lipoprotein cholesterol (LDL-C) in patients with atherosclerotic cardiovascular disease (ASCVD).

> READ MORE